Vera Therapeutics, Inc.
VERA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58 | $49 | $55 | $93 |
| Short-Term Investments | $440 | $508 | $535 | $548 |
| Receivables | $3 | $4 | $4 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $10 | $13 | $7 |
| Total Curr. Assets | $506 | $571 | $606 | $651 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $4 | $0 | $0 |
| Total NC Assets | $11 | $7 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $518 | $579 | $610 | $656 |
| Liabilities | – | – | – | – |
| Payables | $18 | $13 | $9 | $8 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $23 | $20 | $11 | $16 |
| Total Curr. Liab. | $42 | $34 | $22 | $25 |
| LT Debt | $77 | $77 | $53 | $53 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $77 | $77 | $53 | $53 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $4 | $4 |
| Total Liabilities | $119 | $110 | $75 | $79 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$670 | -$589 | -$513 | -$461 |
| AOCI | $1 | $1 | $1 | $0 |
| Other Equity | $1,068 | $1,057 | $1,047 | $1,038 |
| Total Equity | $399 | $468 | $535 | $577 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $518 | $579 | $610 | $656 |
| Net Debt | $19 | $28 | -$1 | -$38 |